(Q33938974)

30 July 2017

1 reference

title

Ambulatory use of parenteral antibacterials: contemporary perspectives (English)

1 reference

30 July 2017

Leggett JE

1

1 reference

30 July 2017

1 January 2000

1 reference

30 July 2017

1 reference

30 July 2017

59 Suppl 3

1 reference

30 July 2017

1-8; discussion 47-9

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200059003-00001

30 July 2017

0 references

cites work

Oral administration of antibiotics: a rational alternative to the parenteral route

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200059003-00001

Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200059003-00001

Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200059003-00001

Continuous infusion of beta-lactam antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200059003-00001

Outpatient intravenous antibiotic therapy. Ten years' experience

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200059003-00001

Treatment of skin and soft-tissue infections utilizing an outpatient parenteral drug delivery device: a multicenter trial. HIAT Study Group

21 January 2018

1 reference

12 December 2020

Antibiotic selection factors and description of a hospital-based outpatient antibiotic therapy program in the USA

1 reference

12 December 2020

Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance

1 reference

12 December 2020

Home intravenous anti-infective therapy (HIVAT): do the benefits outweigh the risks?

1 reference

12 December 2020

Home intravenous therapy in cystic fibrosis: a prospective randomized trial examining clinical, quality of life and cost aspects.

1 reference

12 December 2020

Practice guidelines for community-based parenteral anti-infective therapy. ISDA Practice Guidelines Committee

1 reference

12 December 2020

Safety, efficacy, and cost savings in an outpatient intravenous antibiotic program

1 reference

12 December 2020

Outpatient antimicrobial protocol for febrile neutropenia: a nonrandomized prospective trial using ceftriaxone, amikacin, and oral adjuvant agents

1 reference

12 December 2020

Intramuscular ceftriaxone in home parenteral therapy

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of antibiotics in otitis media

1 reference

12 December 2020

Ambulatory antibiotic infusion devices: extending the spectrum of outpatient therapies

1 reference

12 December 2020

Role for Dual Individualization with Cefmenoxime

1 reference

12 December 2020

Experience with outpatient intravenous teicoplanin therapy for chronic osteomyelitis

1 reference

12 December 2020

Ambulatory treatment with ceftriaxone in febrile neutropenic children.

1 reference

12 December 2020

Use of teicoplanin in community medicine

1 reference

12 December 2020

Secondary bacterial infections in HIV-infected patients: an alternative ambulatory outpatient treatment utilizing intravenous cefotaxime.

1 reference

12 December 2020

Effect of storage of penicillin-G solutions on sensitisation to penicillin-G after intravenous administration

1 reference

12 December 2020

Experience with a physician-directed, clinic-based program for outpatient parenteral antibiotic therapy in the USA

1 reference

12 December 2020

Evolution of outpatient parenteral antibiotic therapy

1 reference

12 December 2020

The pharmacodynamics of beta-lactams

1 reference

12 December 2020

A randomized comparison of the safety and efficacy of once-daily gentamicin or thrice-daily gentamicin in combination with ticarcillin-clavulanate

1 reference

12 December 2020

Pharmacodynamics of levofloxacin: a new paradigm for early clinical trials

1 reference

12 December 2020

Patient selection in outpatient parenteral antimicrobial therapy

1 reference

12 December 2020

Post-antibiotic effects in experimental infection models: relationship to in-vitro phenomena and to treatment of infections in man.

1 reference

12 December 2020

Treatment of streptococcal endocarditis with a single daily dose of ceftriaxone sodium for 4 weeks. Efficacy and outpatient treatment feasibility

1 reference

12 December 2020

Combined ceftriaxone and surgical therapy for osteomyelitis in hospital and outpatient settings

1 reference

12 December 2020

Outpatient parenteral antibiotic therapy. Management of serious infections. Part I: Medical, socioeconomic, and legal issues. Advances in i.v. delivery

1 reference

12 December 2020

Cefonicid in a once-daily regimen for treatment of osteomyelitis in an ambulatory setting

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of outpatient intravenous antimicrobial therapy

1 reference

12 December 2020

Postantibiotic leukocyte enhancement: increased susceptibility of bacteria pretreated with antibiotics to activity of leukocytes

1 reference

12 December 2020

Management of infective complications in patients with advanced hematologic malignancies in home care

1 reference

12 December 2020

Home versus hospital intravenous antibiotic therapy in the treatment of young adults with cystic fibrosis

1 reference

12 December 2020

Outpatient antibiotic therapy for febrile episodes in low-risk neutropenic patients with cancer

1 reference

12 December 2020

Outpatient parenteral antimicrobial-drug therapy

1 reference

12 December 2020

Intravenous antibiotic therapy in an outpatient setting

1 reference

12 December 2020

A pilot study of outpatient management of febrile neutropenic children with cancer at low risk of bacteremia

1 reference

12 December 2020

Multicenter collaborative evaluation of a standardized serum bactericidal test as a predictor of therapeutic efficacy in acute and chronic osteomyelitis

1 reference

12 December 2020

Outpatient use of ceftriaxone: a cost-benefit analysis

1 reference

12 December 2020

Adverse reactions following intravenous penicillin-G relate to degradation of the drug in vitro

1 reference

12 December 2020

Continuous infusion of ceftazidime in cystic fibrosis patients during home treatment: clinical outcome, microbiology and pharmacokinetics

1 reference

12 December 2020

Home intravenous antibiotic therapy using a programmable infusion pump

1 reference

12 December 2020

Penicillin dosing for pneumococcal pneumonia

1 reference

12 December 2020

Ceftriaxone Sodium Therapy of Penicillin G—Susceptible Streptococcal Endocarditis

1 reference

12 December 2020

Correlation of various in vitro testing methods with clinical outcomes in patients with Bacteroides fragilis group infections treated with cefoxitin: a retrospective analysis

1 reference

12 December 2020

Intramuscular meropenem in the treatment of bacterial infections of the urinary and lower respiratory tracts. Italian Intramuscular Meropenem Study Group.

1 reference

12 December 2020

Outpatient parenteral antibiotic therapy. Management of serious infections. Part I: Medical, socioeconomic, and legal issues. Selecting the antibiotic

1 reference

12 December 2020

Practice guidelines for community-based parenteral anti-infective therapy

1 reference

12 December 2020

Outpatient parenteral antimicrobial therapy for osteomyelitis

1 reference

12 December 2020

Efficacy and safety of intravenous cefotaxime for treating pneumonia in outpatients

1 reference

12 December 2020

Choosing an antibiotic on the basis of pharmacodynamics.

1 reference

12 December 2020

Outpatient treatment of endocarditis in a clinic-based program in Argentina

1 reference

12 December 2020

Determinants of efficacy and toxicity of aminoglycosides

1 reference

12 December 2020

Home-based treatment of cellulitis with twice-daily cefazolin

1 reference

12 December 2020

Reducing costs and hospital stay for pneumonia with home intravenous cefotaxime treatment: results with a computerized ambulatory drug delivery system

1 reference

12 December 2020

10.2165/00003495-200059003-00001

Identifiers

DOI

0 references

Dimensions Publication ID

0 references

1 reference

PubMed ID

10845408